Skip to main content

Propionic Acidemia clinical trials at University of California Health

1 research study open to eligible people

Showing trials for
  • Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

    open to eligible people ages 1 year and up

    This First-in-Human (FIH) Phase 1/2 study will evaluate mRNA-3927 in participants 1 year of age and older with propionic acidemia (PA). The study is designed to characterize baseline biomarker levels followed by assessment of safety, pharmacokinetics (PK), and pharmacodynamics (PD) of different doses of mRNA-3927 in participants affected by PA as part of the Dose Optimization phase.

    at UCLA

Last updated: